Pear Bio Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 12

Pear Bio General Information

Description

Developer of proprietary biomedical technologies designed for the treatment of cancer through the measurement of drug resistance on patients. The company's technology uses a proprietary hydrogel that can grow tumors outside the human body and replicate drug resistance to eliminate the trial and error process involved in cancer treatment, enabling patients to receive the right and effective treatment.

Contact Information

Website
www.pearbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • 261 Lester Street
  • Waterloo, Ontario N2L 3W6
  • Canada
+1 (416) 000-0000

Pear Bio Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Pear Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 10-Aug-2020 00000 Completed Generating Revenue
8. Angel (individual) 03-Mar-2020 00000 Completed Generating Revenue
7. Accelerator/Incubator 20-Aug-2019 000.00 00000 00000 Completed Generating Revenue
6. Accelerator/Incubator 15-Jan-2019 000.00 000.00 00000 Completed Generating Revenue
5. Accelerator/Incubator 01-Aug-2018 000.00 Completed Generating Revenue
4. Accelerator/Incubator 31-Mar-2017 000.00 Completed Generating Revenue
3. Accelerator/Incubator 10-Jun-2015 000.00 000.00 Completed Generating Revenue
2. Grant 11-May-2015 $10K Completed Generating Revenue
1. Accelerator/Incubator 01-Feb-2015 Completed Generating Revenue
To view Pear Bio’s complete valuation and funding history, request access »

Pear Bio Patents

Pear Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170312306-A1 Shear-thinning hydrogel, kit and method of preparation Granted 29-Jan-2016 000000000
US-11007215-B2 Shear-thinning hydrogel, kit and method of preparation Active 29-Jan-2016 000000000
US-10413567-B2 Shear-thinning hydrogel, kit and method of preparation Active 29-Jan-2016 000000000
US-10548919-B2 Shear-thinning hydrogel, kit and method of preparation Active 29-Jan-2016 000000000
US-20190374571-A1 Shear-thinning hydrogel, kit and method of preparation Granted 29-Jan-2016 A61K31/74

Pear Bio Executive Team (6)

Name Title Board Seat Contact Info
Duleeka Ranatunga Co-Founder, Chief Executive Officer and Board Member
William Lin Co-Founder, Chief Technology Officer and Board Member
You’re viewing 2 of 6 executive team members. Get the full list »

Pear Bio Board Members (2)

Name Representing Role Since
Duleeka Ranatunga Pear Bio Co-Founder, Chief Executive Officer and Board Member 000 0000
William Lin Pear Bio Co-Founder, Chief Technology Officer and Board Member 000 0000
To view Pear Bio’s complete board members history, request access »

Pear Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pear Bio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crista Galli Ventures Venture Capital Minority 000 0000 000000 0
Hoxton Ventures Venture Capital Minority 000 0000 000000 0
SOSV Venture Capital Minority 000 0000 000000 0
HBS Angels Alumni Association Angel Group Minority 000 0000 000000 0
RebelBio Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »